These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Human embryonic stem cells: from the human embryo transgressed to the regenerative medicine of tomorrow].
    Author: De Vos J, Assou S, Tondeur S, Dijon M, Hamamah S.
    Journal: Gynecol Obstet Fertil; 2009; 37(7-8):620-6. PubMed ID: 19577943.
    Abstract:
    Human embryonic stem cells (hESC) are derived from the inner cell mass (ICM) of the human blastocyst at day 5 or 6 of the early embryo development. These cells display two cardinal features: they are able to differentiate into cell types from many if not all human tissue (pluripotency) and they proliferate strongly and indefinitely without senescence in vitro. Therefore, hESC are a source of choice for stem cells for regenerative medicine and are a reference model to study the biology of pluripotency. Since 2004, the French law (loi de Bioéthique) authorizes hESC research under certain conditions.
    [Abstract] [Full Text] [Related] [New Search]